重新设计的美国放射学委员会16个月核放射学路径:初步结果(2017-2022)
该研究调查了2017年7月1日启动的美国放射学委员会16个月核放射学加速培训路径的125名毕业生,其中69人(55%)完成问卷。大多数毕业生(86%)在住院医师培训后完成了至少一个传统专科培训,62%在学术机构工作,80%目前从事核放射学实践。
要点
- 16个月核放射学路径毕业生中80%目前从事核放射学实践,40%的毕业生核放射学占其工作时间至少50%。
- PET/CT是主要模态/服务(59%),11%的毕业生从事放射诊疗/放射性药物治疗,80%从事核心脏病学。
- 86%的毕业生在住院医师培训后完成了至少一个传统专科培训,成为多亚专科人才,62%在学术机构工作。
核心结论
- 美国放射学委员会16个月核放射学路径的毕业生在学术和社区实践中持续提供核放射学专业知识,该路径预计将继续蓬勃发展。
研究设计与样本
- 对2017年7月1日启动的美国放射学委员会16个月核放射学路径的125名毕业生进行问卷调查,调查时间为2024年3月至5月,69/125(55%)完成问卷。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Launched on July 1, 2017, the redesigned American Board of Radiology 16-month Pathway in Nuclear Radiology is flourishing. The original goal of this accelerated training pathway was to help meet the ever-growing demand for nuclear radiology subspecialists in academic and community practices. As of March 1, 2024, 125 graduates of the 16-month pathway had achieved specialty certification in either diagnostic radiology or interventional radiology/diagnostic radiology; nearly 60% had also attained advanced certification in nuclear radiology and/or nuclear medicine. Between March and May 2024, we surveyed this group of 125 specialty board-certified pathway graduates to evaluate the impact of the pathway on their individual careers and on the overall workforce; 69/125 (55%) respondents completed the survey. The vast majority (86%) pursued at least one traditional fellowship after residency, thus becoming multi-subspecialized. The majority (62%) currently work in an academic setting. The vast majority (80%) currently practice nuclear radiology; 40% of those reported that nuclear radiology comprises at least 50% of their time or typical workload. PET/CT represents the predominant modality/service (59%) and a significant minority (11%) perform radiotheranostics/radiopharmaceutical therapies; the vast majority (80%) practice nuclear cardiology. We anticipate that the ABR 16-month pathway will continue to thrive and that its graduates will continue to bring their expertise in this rapidly expanding domain to their clinical practices and research pursuits to the benefit of radiology, medicine, patients, and society.
引用
- Oates ME, Brugger M, Laszakovits D, et al. The Redesigned American Board of Radiology 16-month Pathway in Nuclear Radiology: Initial Outcomes (2017-2022). Acad Radiol. 2024. PMID: 39643473. doi:10.1016/j.acra.2024.11.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。